Omega-3 fatty acids alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration

Metabolic Brain Disease

Volumn 29, Issue 1, 2014, Pages 185-192

  Model, Camila S ^a,b,c   Gomes, Lara M ^a,b,c   Scaini, Giselli ^a,b,c   Ferreira, Gabriela K ^a,b,c   Gonçalves, Cinara L ^a,b,c   Rezin, Gislaine T ^a,b,c   Steckert, Amanda V ^a,b,c   Valvassori, Samira S ^a,b,c   Varela, Roger B ^a,b,c   Quevedo, João ^a,b,c   Streck, Emilio L ^a,b,c  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia Translacional Em Medicina   (Brazil)

^c Center of Excellence in Applied Neuroscience of Santa Catarina (NENASC)   (Brazil)

Author keywords

Bipolar disorder; Fenproporex; Omega 3 fatty acids; Oxidative stress

Indexed keywords

CARBONYL DERIVATIVE; FENPROPOREX; OMEGA 3 FATTY ACID; PROTEIN; SODIUM CHLORIDE; AMPHETAMINE DERIVATIVE; ANTIOXIDANT; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL STRESS; BRAIN CORTEX; BRAIN DAMAGE; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; HYPERACTIVITY; LIPID PEROXIDATION; LOCOMOTION; MALE; MANIA; NONHUMAN; OXIDATIVE STRESS; PREFRONTAL CORTEX; PROTEIN CONTENT; RAT; ANIMAL; ANIMAL BEHAVIOR; BIPOLAR DISORDER; BRAIN; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; EXPLORATORY BEHAVIOR; HYPERKINESIS; METABOLISM; PROTEIN CARBONYLATION; PSYCHOLOGY; SYNAPTOSOME; WISTAR RAT;

ANIMALIA; RATTUS;

AMPHETAMINES; ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BIPOLAR DISORDER; BRAIN; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FATTY ACIDS, OMEGA-3; HYPERKINESIS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRESYNAPTIC TERMINALS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84895873126     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-013-9473-4     Document Type: Article

References (82)

1. Anand A, Verhoeff P, Seneca N et al (2000) Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 157:1108-1114 (Pubitemid 30432492)
2. Andreazza AC, Cassini C, Rosa AR et al (2007) Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 41:523-529 (Pubitemid 46227446)
3. Andreazza AC, Wang JF, Salmasi F et al (2013) Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem. doi:10.1111/jnc.12316
4. Balanzá-Martínez V, Fries GR, Colpo GD et al (2011) Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev Neurother 11: 1029-1047
5. Barros DM, Izquierdo LA, Medina JH, Izquierdo I (2002) Bupropion and sertraline enhance retrieval of recent and remote long-term memory in rats. Behav Pharmacol 13:215-220 (Pubitemid 34816466)
6. Bas O, Songur A, Sahin O et al (2007) The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus. Neurochem Int 503:548-554 (Pubitemid 46186606)
7. Bazan NG (2009) Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J Lipid Res 50:S400-S405
8. Belmaker RH (2004) Bipolar disorder. N Engl J Med 351:476-486
9. Berger GE, Wood SJ, Wellard RM et al (2008) Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study. Neuropsychopharmacology 33:2467-2473
10. Berk M, Kapczinski F, Andreazza AC et al (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35: 804-817
11. Bielau H, Brisch R, Bernard-Mittelstaedt J et al (2012) Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder. Brain Res 1459:91-99
12. Bird RP, Draper AH (1984) Comparative studies on different methods of malondyhaldehyde determination. Methods Enzymol 105:299-05
13. Clay HB, Sillivan S, Konradi C (2011) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 29:311-324
14. Cody JT, Valtier S, Stillman S (1999) Amphetamine and fenproporex levels following multidose administration of fenproporex. J Ana Toxicol 23:187-194 (Pubitemid 29244532)
15. Coutts RT, Nazarali AJ, Baker GB, Pasutto FM (1986) Metabolism and disposition of N-(2-cyanoethyl) amphetamine (fenproporex) andamphetamine: study in the rat brain. Can J Physiol Pharmacol 64:724-728 (Pubitemid 16046246)
16. Du Bois TM, Deng C, Bell W, Huang XF (2006) Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain. Neurosc 139:1397-03
17. El-Ansary AK, Al-Daihan SK, El-Gezeery AR (2011) On the protective effect of omega-3 against propionic acid-induced neurotoxicity in rat pups. Lipids Health Dis 10:142
18. El-Mallakh RS, El-Masri MA, Huff MO et al (2003) Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disord 5:362-365 (Pubitemid 37361351)
19. Ericson E, Samuelsson J, Ahlenius S (1991) Photocell measurements of rat motor activity. A contribution to sensitivity and variation in behavioral observations. Journal of Pharmacological Methods 25: 111-122
20. Frey BN, Martins MR, Petronilho FC et al (2006a) Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord 8:275-280
21. Frey BN, Valvassori SS, Réus GZ et al (2006b) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31:326-332 (Pubitemid 44497429)
22. Frey BN, Valvassori SS, Réus GZ et al (2006c) Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem Res 31:699-703 (Pubitemid 43886419)
23. Frey BN, Andreazza AC, Kunz M et al (2007) Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog Neuropsychopharmacol Biol Psychiatry 31:283-295
24. Gama CS, Canever L, Panizzutti B et al (2012) Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia. Schizophr Res 141:162-167
25. Gawryluk JW, Wang JF, Andreazza AC et al (2011) Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14:123-130
26. Gigante AD, Andreazza AC, Lafer B et al (2011) Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia. Neurosci Lett 505:47-51
27. Gleissman H, Johnsen JI, Kogner P (2010) Omega-3 fatty acids in cancer, the protectors of good and the killers of evil? Exp Cell Res 316: 1365-1373
28. Gonda X, Pompili M, Serafini G et al (2012) Suicidal behavior in bipolar disorder: Epidemiology, characteristics and major risk factors. J Affect Disord 143:16-26
29. Goodwin FK, Jamison KR (1990) Manic-Depressive Illness: Second Edition New York. Oxford University Press, NY
30. Guest J, Garg M, Bilgin A, Grant R (2013) Relationship between central and peripheral fatty acids in humans. Lipids Health Dis 12:79
31. Haag M (2003) Essential fatty acids and the brain. Can J Psychiatry 48: 195-203
32. Jana S, Sinha M, Chanda D et al (2011) Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease. Biochim Biophys Acta 1812:663-673
33. Kapczinski F, Dal-Pizzol F, Teixeira AL et al (2011) Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 45: 156-161
34. Kato T, Kato N (2000) Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2:180-190
35. Katsumata T, Katayama Y, Obo R et al (1999) Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model. Eur J Pharmacol 372:167-174 (Pubitemid 29251288)
36. Kishi T, Yoshimura R, Fukuo Y et al (2013) The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci 263:105-118
37. Kitajka K, Sinclair AJ, Weisinger RS et al (2004) Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci U S A 101:10931-10936 (Pubitemid 38989562)
38. Konradi C, Eaton M, Macdonald ML et al (2004)Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61:300-308 (Pubitemid 38295832)
39. Kraemer T, Theis GA, Weber AA, Maurer HH (2000) Studies on the metabolism and toxicological detection of the amphetamine-like anorectic fenproporex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay. J Chromatogr B 738:107-118 (Pubitemid 30053098)
40. Kuloglu M, Ustundag B, Atmaca M et al (2002) Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem and Function 20:171-175
41. Kunz M, Gama CS, Andreazza AC et al (2008) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32:1677-1681
42. Lai YL, Rodarte JR, Hyatt RE (1977) Effect of body position on lung emptying in recumbent anesthetized dogs. J Appl Physiol 43:983-987 (Pubitemid 8258269)
43. Lavialle M, Champeil-Potokar G, Alessandri JM et al (2008) An (n-3) polyunsaturated fatty acid-deficient diet disturbs daily locomotor activity, melatonin rhythm, and striatal dopamine in Syrian hamsters. J Nutr 138:1719-1724
44. Leclerc E, Mansur RB, Brietzke E (2013) Determinants of adherence to treatment in bipolar disorder: A comprehensive review. J Affect Disord 149:247-252
45. Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346-357
46. Logan AC (2003) Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev 8:410-425
47. Machado-Vieira R, Kapczinski F, Soares JC (2004) Perspective for the development of animals models of bipolar disorders. Prog Neuro Psycopharmacol Biol Psychiatry 28:209-224 (Pubitemid 38130126)
48. Mattei R, Carlini EA (1996) A comparative study of the anorectic and behavioral effects of fenproporex on male and female rats. Braz J Med Biol Res 29:1025-1030 (Pubitemid 26272905)
49. Mossaheb N, Schäfer MR, Schlögelhofer M et al (2013) Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis:When do they begin to be effective? Schizophr Res. doi: 10.1016/j.schres.2013.05.027
50. Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13:1161-1169
51. Noaghiul S, Hibbeln JR (2003) Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry 160: 2222-2227 (Pubitemid 39619617)
52. Ozyurt B, Sarsilmaz M, Akpolat N et al (2007) The protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat. Neurochem Int 50:196-202 (Pubitemid 44879676)
53. Pinsonneault JK, Han DD, Burdick KE et al (2011) Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder. Neuropsychopharmacology 36: 1644-1655
54. Piomelli D (1994) Eicosanoids in synaptic transmission. Crit Rev Neurbiol 8:65-83
55. Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3-33 (Pubitemid 36205070)
56. Quiroz JA, Gray NA, Kato T, Manji HK (2008) Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33:2551-2565
57. Rajkowska G (2002) Cell pathology in bipolar disorder. Bipolar Disord : 4105-16
58. Rao JS, Lee HJ, Rapoport SI, Bazinet RP (2008) Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol Psychiatry 13:585-596 (Pubitemid 351704942)
59. Rezin GT, Furlanetto CB, Scaini G, et al. (2013) Fenproporex increases locomotor activity, alters energy metabolism and mood stabilizers reverse these changes: a proposal for a new animal model of mania. Molecular Neurobiology, in press.
60. Robinson TE, Kolb B (1997) Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17:8491-8497 (Pubitemid 27461070)
61. Sagduyu K, Dokucu ME, Eddy BA et al (2005) Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study. Nutr J 4:1-6
62. Salem N Jr, Litman B, Kim HY, Gawrish K (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36:945-959 (Pubitemid 33065196)
63. Salomone JD, Cousins MS, Snyder BJ (1997) Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Ver 21:341-359 (Pubitemid 27225155)
64. Serhan CN, Yacoubian S, Yang R (2008) Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 3:279-312 (Pubitemid 351488283)
65. Severino G, Squassina A, Costa M et al (2013) Pharmacogenomics of bipolar disorder. Pharmacogen 14:655-674
66. Siegel G, Ermilov E (2012) Omega-3 fatty acids: benefits for cardio-cerebro-vascular diseases. Atheroscler 225:291-295
67. Sims DE (1991) Recent advances in pericyte biology-implications for health and disease. Can J Cardiol 7:431-443
68. Sinclair AJ, Begg D, Mathai M, Weisinger RS (2007)Omega 3 fatty acids and the brain: review of studies in depression. Asia Pac J Clin Nutr 16:391-397 (Pubitemid 46524632)
69. Sogaard R, Werge TM, Bertelsen C et al (2006) GABA(A) receptor function is regulated by lipid bilayer elasticity. Biochemistry 45: 13118-13129 (Pubitemid 44763435)
70. Sonnewald U, Hertz L, Schousboe A (1998)Mitochondrial heterogeneity in the brain at the cellular level. J Cereb Blood Flow Metab 18:231-237 (Pubitemid 28103630)
71. Soreca I, Frank E, Kupfer DJ (2009) The phenomenology of bipolar disorder:what drives the high rate ofmedical burden and determines long-term prognosis? Depress Anxiety 26:73-82
72. Sosa V, Molin'e T, Somoza T et al (2012) Oxidative stress and cancer: an overview. Ageing Research Review 12:376-390
73. Steckert AV, Valvassori SS, Moretti M et al (2010) Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochem Res 35:1295-1301
74. Stoll AL, Severus WE, Freeman MP et al (1999) Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56:407-412 (Pubitemid 29215428)
75. Strakowski SM, Sax KW (1998) Progressive behavioral response to repeated Damphetamine challenge: further evidence for sensitization in humans. Biol Psychiatry 44:1171-1177 (Pubitemid 28547152)
76. Vawter MP, Tomita H, Meng F et al (2006) Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Molecular psychiatry 11:663-679 (Pubitemid 43989813)
77. Wall R, Ross RP, Fitzgerald GF, Stanton C (2010) Fatty acids from fish: the antiinflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68:280-289
78. Wang JF, Shao L, Sun X, Young LT (2009) Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord 11:523-529
79. Wu A, Ying Z, Gomez-Pinilla F (2004) Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 21:1457-1467 (Pubitemid 39435321)
80. Wu A, Ying Z, Gomez-Pinilla F (2008) Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neurosci 155:751-759
81. Wultz B, Sagvolden T, Moser EI, Moser MB (1990) The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. Behav Neural Biol 53:88-102 (Pubitemid 20111365)
82. Young G, Conquer J (2005) Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev 45:1-28 (Pubitemid 40528530)